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asopressin regulates body water conservation by
redistributing aquaporin-2 (AQP2) water channels
from intracellular vesicles to the apical surface of
renal collecting ducts, resulting in water reabsorption from
urine. Mutations in 
 
AQP2
 
 cause autosomal nephrogenic
diabetes insipidus (NDI), a disease characterized by the
inability to concentrate urine. Here, we report a frame-shift
mutation in 
 
AQP2
 
 causing dominant NDI. This AQP2 mutant
is a functional water channel when expressed in 
 
Xenopus
 
oocytes. However, expressed in polarized renal cells, it is
V
 
misrouted to the basolateral instead of apical plasma mem-
brane. Additionally, this mutant forms heterotetramers with
wild-type AQP2 and redirects this complex to the basolateral
surface. The frame shift induces a change in the COOH
terminus of AQP2, creating both a leucine- and a tyrosine-
based motif, which cause the reversed sorting of AQP2.
Our data reveal a novel cellular phenotype in dominant
NDI and show that dominance of basolateral sorting motifs
in a mutant subunit can be the molecular basis for disease.
 
Introduction
 
The renal action of the antidiuretic hormone arginine vaso-
pressin (AVP) is essential in order to maintain osmo- and
volume balance. With hypernatremia and hypovolemia,
AVP is released from the pituitary and binds the vasopressin
type-2 receptor at the basolateral side of collecting duct cells.
Receptor occupation initiates a cAMP- and calcium-signaling
cascade (Chou et al., 2000) that induces tethering of activated
protein kinase A (PKA) to intracellular vesicles containing
aquaporin-2 (AQP2; Klussmann et al., 1999). Subsequently,
phosphorylation of minimally three monomers of an AQP2
tetramer, and possibly other proteins, results in a redistribution
of AQP2 from intracellular vesicles to the apical plasma
membrane, rendering this membrane water permeable
(Nielsen et al., 1993; Katsura et al., 1997; Kamsteeg et al.,
2000). Driven by the osmotic gradient, urinary water will
then enter the cells via AQP2 and exit the cells to the in-
terstitium via AQP3 and AQP4, which are constitutively
present in the basolateral membrane.
In nephrogenic diabetes insipidus (NDI), this process of
urine concentration is disturbed. Consequently, these humans
suffer from polyuria and polydipsia. In congenital NDI, the
autosomal form is caused by mutations in the 
 
AQP2
 
 gene
(Deen et al., 1994). Expressed in 
 
Xenopus
 
 oocytes or mam-
malian cells, missense AQP2 mutants encoded in recessive
NDI are misfolded and retained in the ER (Deen and
Brown, 2001; Marr et al., 2002a). In dominant NDI, one
missense and four (
 
 
 
1) frame-shift mutations of 
 
AQP2
 
 have
been described (Mulders et al., 1998; Kuwahara et al., 2001;
Marr et al., 2002b). The missense mutation encodes a
mutant (AQP2-E258K) that is localized to the Golgi com-
plex region in oocytes, whereas the mutants encoded by
(
 
 
 
)1 frame shift mutations are localized to the endosomal/
lysosomal compartments and/or the basolateral plasma mem-
brane. The concomitant proteins are able to form het-
ero-oligomers with wild-type (wt) AQP2, in contrast to
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mutants in recessive NDI. The subsequent impaired routing
of wt-AQP2 to the plasma membrane explains the dominant
mode of inheritance of NDI (Kamsteeg et al., 1999; Kuwa-
hara et al., 2001; Marr et al., 2002b). However, the molecu-
lar mechanism underlying the missorting of all mutants in
dominant NDI is still unknown.
Here, we report a (
 
 
 
1) frame-shift mutation in the AQP2
gene causing dominant NDI. This mutant forms heterotet-
ramers with wt-AQP2, and these complexes are missorted to
the basolateral (instead of apical) plasma membrane. The
frame shift results in a mutant AQP2 protein with a COOH
terminus that is different from that of wt-AQP2 or the other
mutants in dominant NDI. In this unique COOH termi-
nus, we identified two basolateral sorting motifs that are re-
sponsible for the reversed sorting. These data provide the
first molecular mechanism underlying the missorting of
AQP2 in dominant NDI, and show for the first time that a
dominant disease can result from a mutation that creates a
basolateral sorting motif in a mutant subunit.
 
Results
 
Analysis of a family with dominant NDI
 
The proband P1 (Fig. 1) was referred to the clinic for a life-
long history of polyuria, polydipsia (8–10 l/d), and dilated
bladder and ureters, as determined by ultrasound. Five of his
six children and one grandchild (P2–7) also had polyuria
and polydipsia. Clinical analyses of blood and urine revealed
that all affected members of this family demonstrated mild
hypernatremia (150 mmol/l) with concomitant low urine
osmolarities (
 
 
 
200 mosM/kg H
 
2
 
O) that did not increase af-
ter administration of the synthetic vasopressin analogue
dDAVP. Therefore, NDI was diagnosed.
Subsequent segregation analysis within this family re-
vealed that NDI cosegregated in a dominant fashion with
markers located close to the AQP2 gene locus (Fig. 1). Se-
quence analysis of the complete 
 
AQP2
 
 gene from five pa-
tients (P1, 3–5, and 7) and four unaffected relatives (U1–4)
revealed three mutations in the 
 
AQP2
 
 allele of the patients,
but not in those of the healthy subjects. These mutations
were a silent c501C
 
 
 
T mutation in exon 2, an insertion of
an adenosine in exon 4 (c779-780insA), and a c836A
 
 
 
C
mutation in the 3
 
 
 
 UTR. The c501C
 
 
 
T and c836A
 
 
 
C
mutations are polymorphisms occurring with a frequency of
0.1 (
 
n
 
 
 
  
 
62) or 0.4 (
 
n
 
 
 
  
 
53; Marr et al., 2002b), respec-
tively. However, the adenosine insertion causes a COOH-
terminal frame shift that changes the last 12 amino acids of
the AQP2 protein. In addition, with the c836A
 
 
 
C muta-
tion in the same allele, which changes the new triplet TAA
(stop codon) into TAC (Tyr), the C-tail of the encoded pro-
tein, which we denote AQP2-insA, is further extended with
14 amino acids (Fig. 2).
 
AQP2-insA is a functional water channel mainly 
localized in the plasma membrane
 
To determine the molecular cause of dominant NDI in this
family, oocytes were injected with different amounts of
cRNAs encoding wt-AQP2 or AQP2-insA. The osmotic wa-
ter permeability (P
 
f
 
) of AQP2-insA–expressing oocytes was
significantly increased compared with noninjected oocytes,
which indicated that AQP2-insA is a functional water chan-
nel. However, this P
 
f
 
 was slightly (but significantly) reduced
compared with that of oocytes expressing wt-AQP2 (Fig. 3
A). To determine whether the reduced P
 
f
 
 of AQP2-insA was
due to an overall lower expression level or reduced expres-
sion in the plasma membrane, total membranes and plasma
membranes of the same oocytes were isolated and subjected
to immunoblotting. In parallel, a serial dilution series of wt-
AQP2 was immunoblotted to relatively quantify the
obtained signals. With injections of 
 
 
 
0.3 ng, at which P
 
f
 
values are in a linear range (Kamsteeg and Deen, 2000), wt-
AQP2 and AQP2-insA were expressed at similar levels, but
less AQP2-insA was detected in the plasma membrane frac-
tion (Fig. 3 B). This indicated that the reduced P
 
f
 
 of oocytes
expressing AQP2-insA is caused by a slight intracellular re-
tention of AQP2-insA compared with wt-AQP2.
Fluorescence microscopy revealed that, in line with the si-
miliar osmotic water permeabilities of AQP2-insA– and wt-
AQP2–expressing oocytes, both AQP2-insA and wt-AQP2
were mainly expressed in the oocyte’s plasma membrane
Figure 1. Segregation of autosomal dominant NDI within the 
studied family. Healthy (open symbols) and affected (filled symbols) 
individuals, and male (squares) and females (circles) are indicated. 
The 12q13 haplotype is represented using the marker order: 
centromere-AFM259vf9-AQP2-D12S131-AFMb007yg5-telomere. 
The lengths of simple sequence tags in nucleotides (AFM259vf9 
[1:313; 2:315], D12S131 [3:156; 4:158], AFMb007yg5 [b:226; 
d:230; j:242]), the C or T polymorphism in exon 2, 779-780insA 
nucleotide insertion (i) or normal sequence (n), and the A or C poly-
morphism in the 3  UTR of AQP2 are indicated.
Figure 2. COOH termini of wt-AQP2 and AQP2-insA. The COOH-
terminal amino acids (one-letter symbols) and corresponding nucle-
otide sequences of wild-type aquaporin-2 (wt-AQP2) and AQP2-
insA are shown, starting at aa 253. The c779-780insA and c836A C 
mutations, identified in the mutant AQP2 allele of the patient, are 
underlined and bold. An asterisk indicates a stop codon. 
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(Fig. 3 C). These data indicated that AQP2-insA is a func-
tional water channel and that the dominant phenotype of
AQP2-insA could not be demonstrated in oocytes.
 
AQP2-insA is redistributed from intracellular vesicles 
to the basolateral plasma membrane
 
Because renal collecting duct cells are epithelial cells, in con-
trast to oocytes, we speculated that the dominant phenotype
might become clear when AQP2-insA would be expressed in
the epithelial MDCK (type I) cells, which are derived from
renal collecting ducts. Heterologously expressed in these
cells, wt-AQP2 is redistributed from vesicles to the apical
membrane on stimulation with AVP or forskolin (Deen et
al., 1997). Therefore, MDCK cell lines stably expressing
Figure 3. Expression of AQP2-insA in oocytes. (A) Water permeabil-
ities. Oocytes were not injected (control), or injected with the indicated 
amounts of cRNA encoding wild-type AQP2 (wt-AQP2), AQP2-insA, 
AQP2-insA-R273* (insA-R273*), or AQP2-insA-G268* (insA-G268*). 
2 d after injection, the mean water permeability (Pf   SEM [in  m/s]; 
n  12) was determined in a standard swelling assay. (B) AQP2 protein 
expression levels. Total membranes (TM) and plasma membranes 
(PM) of oocytes that were used for the Pf measurements were isolated, 
and equivalents of four oocytes were immunoblotted. To allow 
comparison of AQP2 protein amounts, the membranes were incubated 
with AQP2 antibodies that were completely preabsorbed with a 
synthetic peptide raised against the last 15 amino acids of wt-AQP2 
(not depicted). Complex glycosylated and nonglycosylated AQP2 
proteins are indicated by c-AQP2 and AQP2, respectively. (C) Sub-
cellular localization of AQP2-insA proteins. 2 d after injection, non-
injected oocytes (control) and oocytes injected with 0.3 ng cRNA 
encoding the indicated AQP2 proteins were fixed and embedded in 
paraffin. On 5- m sections, AQP2 was visualized using rabbit AQP2 
antibodies, followed by Alexa
® 594–conjugated anti–rabbit IgGs. 
Arrows indicate the plasma membrane.
Figure 4. Localization of AQP2-insA in MDCK cells. MDCK cells 
expressing AQP2-insA (A) or wt-AQP2 (B) were grown to confluence, 
incubated without (control) or with forskolin, fixed, and immuno-
stained using guinea pig AQP2-insA antibodies followed by an 
incubation with Alexa
® 594–conjugated anti–guinea pig IgGs (red) 
or rabbit AQP2 antibodies, followed by Alexa
® 488–conjugated 
anti–rabbit IgGs (green). The basolateral marker protein E-cadherin 
was visualized using specific rat antibodies followed by Cy5-
conjugated anti–rat IgGs. Horizontal (XY) and vertical (XZ) images 
for AQP2-insA, wt-AQP2, and E-cadherin were obtained with a 
confocal laser-scanning microscope and merged (merge). 
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AQP2-insA were obtained and analyzed. Immunocyto-
chemistry and confocal laser-scanning microscopy (CLSM)
analysis revealed that without stimulation, AQP2-insA was
mainly localized in intracellular vesicles, which were differ-
ently distributed than those containing wt-AQP2 (Fig. 4, A
and B; control). In addition, forskolin stimulation resulted
in redistribution of AQP2-insA to the basolateral mem-
brane, at which it colocalized with the basolateral marker
protein E-cadherin (Fig. 4 A, forskolin). In contrast, wt-
AQP2 was redistributed from intracellular vesicles to the
apical membrane on stimulation (Fig. 4 B, forskolin).
 
AQP2-insA forms hetero-oligomers with wt-AQP2
 
The missorting of hetero-oligomers of wt-AQP2 and its mu-
tants was shown to provide an explanation for dominant
NDI. To study if AQP2-insA would cause NDI through a
similar mechanism, membranes of MDCK cells expressing
wt-AQP2, AQP2-insA, or AQP2-R187C (a mutant in re-
cessive NDI) were solubilized and subjected to differential
velocity centrifugation. Immunoblot analysis of gradient
fractions and comparison of their signal peak fraction with
that of marker proteins revealed that AQP2-insA and wt-
AQP2 have sedimentation coefficients in between 4.3 and
7.4 (Fig. 5 A). These coefficients conform to expression of
AQP1 and AQP4 as homotetramers because the homotet-
rameric AQP1 and AQP4 are 
 
 
 
5.7 
 
s
 
 and 5.2–6.8 
 
s
 
, respec-
tively (Smith and Agre, 1991; Neely et al., 1999). As shown
before in oocytes (Kamsteeg et al., 1999), AQP2-R187C,
which is expressed as nonglycosylated (29 kD) and high-
mannose glycosylated (32 kD) forms, has a sedimentation
coefficient of 
 
 
 
4.3 (Fig. 5 A), which indicated that AQP2-
R187C is also expressed as a monomer in MDCK cells.
To determine whether wt-AQP2 and AQP2-insA hetero-
ligomerize, wt-AQP2–expressing cells were supertransfected
with an expression construct encoding VSV-G–tagged
AQP2-insA (V-AQP2-insA). This tag, which does not inter-
fere with the basolateral localization of AQP2-insA, allows
discrimination of AQP2-insA from wt-AQP2 on immuno-
blot because it retains its migration on SDS-PAGE. Repre-
sentative clonal cell lines expressing similar levels of both wt-
AQP2 and V-AQP2-insA (Fig. 5 B, top left, third lane), or
wt-AQP2 and AQP2-insA alone were grown to confluence.
Total membranes were isolated, solubilized, and directly im-
munoblotted or subjected to immunoprecipitation using
AQP2-insA–specific antibodies. Detection of transferred
proteins from total membranes with AQP2 antibodies
(which recognize wt-AQP2 and AQP2-insA) and AQP2
COOH-terminal antibodies (which recognize only wt-
AQP2) confirmed the expression of wt-AQP2 or AQP2-
insA in the single transfectants and of wt-AQP2 and
V-AQP2-insA in coexpressing cells (Fig. 5 B). Analysis of
the immunoprecipitates (bottom) revealed that wt-AQP2
coprecipitated with V-AQP2-insA, which indicated that
AQP2-insA and wt-AQP2 formed hetero-oligomers. Similar
results were obtained when these proteins were (co)expressed
in oocytes (unpublished data).
 
AQP2-insA directs wt-AQP2 to the
basolateral membrane
 
When expressed alone, wt-AQP2 is sorted to the apical
plasma membrane and AQP2-insA to the basolateral plasma
membrane of MDCK cells. Because their coexpression in
MDCK cells results in the formation of hetero-oligomers,
we analyzed where these complexes were sorted to. Immu-
nocytochemistry and CLSM analysis showed that wt-AQP2
and V-AQP2-insA colocalized to a large extent in intracellu-
lar vesicles (Fig. 6 A, control). On stimulation with forsko-
lin, wt-AQP2 was translocated to the basolateral membrane
together with V-AQP2-insA (Fig. 6 A, forskolin). As a nega-
tive control, wt-AQP2–expressing MDCK cells were super-
Figure 5. Oligomerization state of AQP2-insA. (A) Homotetramer-
ization. Membranes of MDCK cells expressing the indicated AQP2 
proteins were dissolved in deoxycholate and subjected to differential 
velocity centrifugation. Fractions were collected from the top, of 
which fractions B–P were immunoblotted for AQP2. The fractions 
with peak intensities of the marker proteins ovalbumin (3.6 s), BSA 
(4.3 s), phosphorylase B (5.2 s), yeast alcohol dehydrogenase (7.4 s), 
and catalase (11.2 s) are indicated by arrows and by their sedimentation values. The molecular masses (in kD) of the respective AQP2 proteins 
are indicated on the left. (B) Heteroligomerization of AQP2-insA with wt-AQP2. Membranes of MDCK cells expressing wt-AQP2 (wt), AQP2-
insA (insA), or VSV-G-tagged AQP2-insA together with wt-AQP2 (V-insA   wt) were solubilized in deoxycholate and centrifuged to remove 
nonsolubilized material. The supernatants were directly subjected to immunoblotting (TM, total membranes) or subjected to immunoprecipitation 
with affinity-purified AQP2-insA antibodies (insA IPs), followed by immunoblotting. Transferred AQP2 proteins were detected with rabbit 
AQP2 antibodies that recognize wt-AQP2 and AQP2-insA, or with affinity-purified rabbit AQP2 COOH-terminal antibodies (AQP2 C-term 
antibodies) that do not recognize AQP2-insA. Specific bands for VSV-G–tagged AQP2-insA (V-insA) and untagged AQP2 proteins (AQP2) 
are indicated on the right. 
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transfected with an expression construct encoding AQP2-
R187C, which was NH
 
2
 
-terminally tagged with GFP
(G-AQP2-R187C; for consistency, wt-AQP2 is given in
green, and G-AQP2-R187C is shown in red). In these cells,
wt-AQP2 showed a vesicular expression pattern and shifted
to the apical plasma membrane upon forskolin stimulation
(Fig. 6 B). However, G-AQP2-R187C showed a dispersed
staining that was clearly different from that of wt-AQP2 and
did not change upon forskolin treatment (Fig. 6 B). These
results revealed that assembly of wt-AQP2/AQP2-insA com-
plexes resulted in the sorting of wt-AQP2 to the basolateral
membrane, which provides an explanation for dominant
NDI in this particular family.
 
AQP2-insA contains two basolateral sorting signals
 
The basolateral sorting of AQP2-insA could be caused by
the loss of apical sorting signals contained in the COOH
terminus of wt-AQP2 or by the presence of basolateral sort-
ing signals in the COOH-terminal tail of AQP2-insA. To
analyze whether lacking the COOH-terminal tail of wt-
AQP2 could be the cause of the basolateral sorting of
AQP2-insA, MDCK clones stably expressing AQP2-S261*
were made. The translation of this mutant is stopped,
whereas in AQP2-insA the reading frame changes. Forskolin
induced a translocation of AQP2-S261* from vesicles to the
apical membrane (Fig. 7 A, w-S261*), although this was less
efficient as found for wt-AQP2. However, this indicated
that the basolateral sorting of AQP2-insA was not caused by
a deletion of an apical determinant in wt-AQP2, but by ba-
solateral sorting information in the COOH terminus of
AQP2-insA.
To identify such information in AQP2-insA, constructs
encoding AQP2-insA with stop codons after D282, Y279,
R273, G268, or E264 were made and stably transfected to
MDCK cells. All these truncation mutants were still sorted
to the basolateral plasma membrane, with varying depen-
dence on forskolin stimulation (Fig. 7 A). Therefore, the
COOH-terminal four amino acids in AQP2-insA-E264*
should contain a basolateral sorting signal, because this
stretch of amino acids was the only difference with AQP2-
S261*. Because leucine-based motifs in cytoplasmic tails can
mediate sorting to the basolateral membrane (Heilker et al.,
1999; Wehrle-Haller and Imhof, 2001), the involvement of
L261 in the basolateral sorting of AQP2-insA was analyzed.
Indeed, substitution of alanine for L261 in AQP2-insA-
G268* (AQP2-insA-L261A-G268*) resulted in localization
in the apical plasma membrane. To confirm the role of L261
in the basolateral sorting of AQP2-insA, the L261A substi-
tution was introduced into the full-length AQP2-insA,
AQP2-insA-L261A. However, this mutant is translocated to
the basolateral surface, which indicated that another basolat-
eral sorting determinant must be present downstream of
L261. Tyrosine-based motifs with the consensus YXXØ (X
is any amino acid; Ø is an amino acid with a bulky hydro-
phobic side chain) are also known basolateral sorting sig-
nals (Hunziker et al., 1991; Folsch et al., 1999), and the
Y
 
269
 
QGL sequence in AQP2-insA fits to this consensus. Be-
cause the tyrosine is critical in this element, the Y269A sub-
stitution was introduced into AQP2-insA and AQP2-insA-
L261A. CLSM analysis revealed that AQP2-insA-Y269A
was sorted to the basolateral plasma membrane, whereas
AQP2-insA-L261A-Y269A was sorted to the apical plasma
membrane (Fig. 7). Thus, our data show that two motifs are
involved in the basolateral sorting of AQP2-insA.
Figure 6. Colocalization and regulation of AQP2-insA and wt-AQP2 
in MDCK cells. (A) MDCK cells coexpressing wt-AQP2 and VSV-G–
tagged AQP2-insA were incubated without (control) or with forskolin, 
fixed, and incubated with rabbit AQP2 COOH-terminal antibodies 
and guinea pig AQP2-insA antibodies, followed by Alexa
® 488–
conjugated anti–rabbit IgGs (green) and Alexa
® 594–conjugated 
anti–guinea pig IgGs (red). Horizontal (XY) and vertical (XZ) images 
for wt-AQP2 and VSV-G–tagged AQP2-insA (V-AQP2-insA) were 
obtained with a confocal laser-scanning microscope and merged 
(merge). (B) MDCK cells heterologously expressing wt-AQP2 were 
supertransfected with a plasmid encoding GFP-tagged AQP2-
R187C, and GFP-positive cells were selected using FACS
® analysis. 
These pooled cells were grown to confluence on filter supports, 
treated as under A, and incubated with rabbit AQP2 COOH-terminal 
antibodies that recognize both wt-AQP2 and AQP2-R187C 
(wt-AQP2   G-AQP2-R187C), followed by Alexa
® 594–conjugated 
anti–rabbit IgGs (shown in green pseudocolor). The GFP signal of 
AQP2-R187C (G-AQP2-R187C) is given the red pseudocolor. 
Horizontal (XY) and vertical (XZ) images for were obtained with 
a confocal laser-scanning microscope and merged (merge). 
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Phosphorylation of AQP2-insA at S256 induces its 
redistribution to the basolateral membrane
 
Both wt-AQP2 and AQP2-insA redistributed from intra-
cellular vesicles to the plasma membrane with forskolin
(Fig. 4 and Fig. 7 A). For wt-AQP2, this translocation de-
pends on phosphorylation of S256 in its COOH terminus
by PKA (Katsura et al., 1997; van Balkom et al., 2002).
Phosphorylation-state mutants of AQP2 perfectly mimic
this effect (i.e., AQP2-S256A is localized in intracellular
vesicles, whereas AQP2-S256D is present in the apical
plasma membrane, both with or without forskolin; van
Balkom et al., 2002). Because AQP2-insA still contains
this PKA consensus site, we tested its role in the shuttling
of AQP2-insA by introducing the S256A and S256D mu-
tations. Indeed, CLSM analysis revealed that AQP2-
S256A-insA was retained in intracellular vesicles, whereas
AQP2-S256D-insA was localized in the basolateral mem-
brane, independent of forskolin treatment (Fig. 7 A).
These data indicated that the translocation of AQP2-insA
from intracellular vesicles to the basolateral membrane
also relies on the phosphorylation of S256 in its COOH
terminus.
 
The YXXØ motif in AQP2-insA causes a decrease 
in surface expression
 
The obvious differences in plasma membrane expression lev-
els of the AQP2-insA mutants with or without forskolin
(Fig. 7 A) indicated that S256 phosphorylation is not the
only determinant of their subcellular localization. To iden-
tify other elements involved in this behavior, we performed
computer-assisted image analysis of the cell surface/intracel-
lular expression pattern, in which colocalization with E-cad-
herin was used to identify the basolateral plasma membrane
(unpublished data). This analysis revealed three different
phenotypes (Fig. 7 B). First, similar to wt-AQP2 and
AQP2-insA, several mutants show a predominant intracellu-
lar staining without forskolin and a marked translocation to
the plasma membrane after forskolin stimulation (AQP2-
insA-D282*, -Y279*, -L261A, and -Y269A). Second, some
mutants are already mainly present in the cell surface with-
Figure 7. Subcellular localization of AQP2-insA 
mutants in MDCK cells. (A) MDCK cells stably 
expressing AQP2-S261* (wt-S261*) or AQP2-insA 
mutants (indicated by insA or introduced mutations; 
asterisks indicate stop codons) were incubated 
without (control) or with forskolin, fixed, and 
immunostained for AQP2 proteins using rabbit 
AQP2 and Alexa
® 594–conjugated anti–rabbit 
antibodies. XZ images were made with a confocal 
laser-scanning microscope. (B) Mean values of 
integrated OD of surface or intracellular staining 
of AQP2 proteins were obtained from confocal 
laser-scanning microscope images. The ratio be-
tween surface and intracellular expression (ratio 
surface/intracellular   SEM; n   8) is determined 
from these values. Gray bars indicate this ratio 
from untreated cells, total bars indicate this ratio 
after forskolin stimulation. 
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out forskolin stimulation (AQP2-insA-G268*, -L261A-
G268*, and -L261A-Y269A). Third, three mutants show a
marked decrease in their plasma membrane expression, even
after forskolin stimulation (wt-AQP2-S261*, and AQP2-
insA-E264* and -R273*). In the latter group, wt-AQP2-
S261* and AQP2-insA-E264* are probably inefficiently
sorted due to their short COOH termini. Strikingly, how-
ever, all AQP2-insA mutants that contain the YXXØ motif
are vesicularly localized when untreated, whereas AQP2-
insA-R273*, which has the YXXØ motif at its extreme
COOH terminus, even remains intracellularly localized
when stimulated with forskolin. In contrast, those that lack
this motif are already partially localized in the plasma mem-
brane in untreated cells.
Involvement of the YXXØ motif in vesicular localization
is also supported from the oocyte analyses. At similar total
expression levels, AQP2-insA was expressed at lower levels in
the plasma membrane than wt-AQP2 (Fig. 3 B). Therefore,
AQP2-insA-R273* and AQP2-insA-G268* were also ex-
pressed in oocytes. Compared with wt-AQP2 or AQP2-
insA, oocytes expressing AQP2-insA-R273* showed a
strongly reduced P
 
f
 
, whereas the P
 
f
 
 of oocytes expressing
AQP2-insA-G268* was not different from those injected
with the corresponding amount of wt-AQP2 cRNA (Fig. 3
A). Immunoblot analysis of total and plasma membrane
fractions of these oocytes revealed that the total expression
levels of wt-AQP2 and the three mutants were similar (Fig.
3 B, TM; 0.3-ng injections). The plasma membrane expres-
sion of AQP2-insA-G268* was similar to that of wt-AQP2,
whereas AQP2-R273* was not detected in the plasma mem-
brane fraction at all (Fig. 3 B), even at higher expression lev-
els (unpublished data). The reason for the slower migration
of AQP2-insA-R273* in SDS-PAGE is unclear, but consis-
tent in oocytes (Fig. 3 B) and MDCK cells (unpublished
data). Consistent with the functional and biochemical data,
immunocytochemistry of these oocytes revealed that AQP2-
insA-R273* was predominantly localized in intracellular ves-
icles, whereas AQP2-insA-G268* was, as wt-AQP2, only de-
tected in the plasma membrane (Fig. 3 C). Altogether, these
data reveal that the YXXØ motif in AQP2-insA causes a de-
creased plasma membrane localization of this mutant.
 
Discussion
 
AQP2-insA is missorted to the basolateral 
plasma membrane
 
Here, we report a new mutant in dominant NDI, AQP2-
insA, which was mainly expressed in the plasma membrane
of oocytes and sorted to the basolateral (instead of the api-
cal) plasma membrane of MDCK cells (Fig. 3 and Fig. 4 A).
This is similar to the localization of other basolateral pro-
teins, such as AQP3/4, I’m not dead yet (Indy), and the in-
wardly rectifying potassium channel Kir2.1, when expressed
in oocytes (Ishibashi et al., 1994; Jung et al., 1994; Knauf et
al., 2002; Wild and Paysan, 2002). Five other AQP2 gene
mutations in dominant NDI have been reported that encode
AQP2-E258K and four nucleotide deletion mutants (Mul-
ders et al., 1998; Kuwahara et al., 2001; Marr et al., 2002b).
In contrast to AQP2-insA, all five mutants are largely im-
paired in their routing to the plasma membrane in oocytes.
AQP2-E258K is missorted to the Golgi complex region of
oocytes, whereas the aberrant localization of the four dele-
tion mutants has not yet been determined in these cells. Pre-
viously, we described that one of the deletion mutants,
AQP2–727delG, accumulated in late endosomes/lysosomes
and, to some extent, in the basolateral plasma membrane of
MDCK cells (Marr et al., 2002b). Because the other dele-
tion mutants in dominant NDI (721delG, del763–772, and
del812–818) have a similar extended COOH terminus as
AQP2–727delG, due to a (
 
 
 
1) reading frame shift, and are
also retained in oocytes, their complete localization to the
basolateral plasma membrane of MDCK cells (Asai et al.,
2003) was rather surprising.
 
Phosphorylation of AQP2-insA is required for its 
basolateral plasma membrane insertion
 
In wt-AQP2, phosphorylation of S256 is essential for its
translocation from vesicles to the apical plasma membrane
(van Balkom et al., 2002). The localization of AQP2-insA-
S256A and AQP2-insA-S256D reveals that phosphorylation
of S256 is also fundamental to the forskolin-induced trans-
location of AQP2-insA, albeit here from vesicles to the baso-
lateral plasma membrane. This corroborates with the current
opinion that trafficking to both plasma membranes of
MDCK cells is regulated by (de)phosphorylation events
(Brewer and Roth, 1995). Due to the high intracellular
cAMP levels (Hoffman et al., 1994; Xu et al., 1996), AQP2
is completely phosphorylated in oocytes, and therefore pre-
dominantly present in the plasma membrane (Kamsteeg et
al., 2000). Therefore, it is not surprising that AQP2-insA is
also located in the plasma membrane of oocytes.
 
A leucine- and a tyrosine-based motif cause basolateral 
sorting of AQP2-insA
 
Routing experiments have shown that dileucine motifs (in
which one may be replaced by isoleucine, valine, or methio-
nine) and tyrosine-based motifs in cytoplasmic termini often
target proteins to the basolateral plasma membrane (Sando-
val and Bakke, 1994; Heilker et al., 1999). Although both a
dileucine- and a tyrosine-based motif were needed for baso-
lateral expression of the interleukin-6 receptor gp80 (Mc-
Clure and Robinson, 1996), most proteins contain one di-
leucine- or tyrosine-based element, which is sufficient for their
basolateral sorting. To identify the segments conferring the
basolateral sorting of the wt-AQP2/AQP2-insA complexes,
several mutants were analyzed for their subcellular localiza-
tion before and after forskolin stimulation. This revealed
that AQP2-insA was targeted to the apical membrane when
L261 and Y269 were both absent, but not independently
(Fig. 7). These data clearly revealed that, like AQP4 (Madrid
et al., 2001), AQP2-insA contains two independently acting
basolateral sorting motifs. The Y
 
269
 
QGL sequence meets the
criteria for a canonical tyrosine-based sorting motif. These
tyrosine-based motifs can be recognized by adaptor protein
complexes (APs), which direct sorting. Six different APs
(1A, 1B, 2, 3A, 3B, and 4) have been identified with differ-
ent functions and or tissue distribution (Robinson and Bo-
nifacino, 2001). AP1B and AP4 are thought to direct baso- 
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lateral sorting (Folsch et al., 1999; Simmen et al., 2002) and
therefore, could also be involved in basolateral sorting of
AQP2-insA. L261 in AQP2-insA is not part of a typical
dileucine motif because it is not flanked by an isoleucine, va-
line, or methionine. However, it has recently been reported
that a single leucine is sufficient for basolateral sorting of the
stem cell factor (Wehrle-Haller and Imhof, 2001). There-
fore, L261 in AQP2-insA seems to be the second monoleu-
cine identified that is able to target a protein to the baso-
lateral membrane. To date, no interaction partners for
monoleucine motifs have been identified. The basolateral
missorting of AQP2-insA by two COOH-terminal motifs
comprise the first molecular mechanism underlying the mis-
sorting of AQP2 in dominant NDI.
 
The tyrosine-based motif of AQP2-insA also decreases 
surface expression
 
The tyrosine-based motif in AQP2-insA seems to decrease its
surface expression because AQP2-insA mutants that still con-
tain this motif showed a clear intracellular localization in both
oocytes and MDCK cells (Fig. 3 and Fig. 7). In contrast,
those that lack this motif are readily present in the oocyte
plasma membrane, and partially localized to the plasma mem-
brane of untreated MDCK cells. Besides directing basolateral
sorting, tyrosine-based motifs are also involved in endocytosis,
although with somewhat different sequence requirements
(Hunziker et al., 1991; Prill et al., 1993). Therefore, the tyro-
sine-based motif of AQP2-insA probably also acts as an inter-
nalization motif. Typically, AP2 is involved in rapid endocy-
tosis of proteins with tyrosine-based motifs (Nesterov et al.,
1999). Data from Ohno et al. (1996) show that the interac-
tion of a tyrosine-based sorting motif with AP2 is strongest
when located at the COOH-terminal end. Similarly, AQP2-
insA-R273*, which also has its tyrosine-based motif at its ex-
treme COOH terminus, is predominantly intracellularly lo-
calized in oocytes and remains mainly localized in vesicles of
MDCK cells after forskolin treatment.
 
A novel cellular phenotype in dominant NDI: 
two independent basolateral sorting motifs 
in AQP2-insA subunits overrule apical targeting 
signals in wt-AQP2 subunits
 
In MDCK cells, hetero-oligomers of wt-AQP2 and AQP2-
insA are missorted to the basolateral plasma membrane due
to basolateral sorting motifs in the mutant (Fig. 6 A). Ex-
trapolated to the kidney, the missorting of wt-AQP2 to the
basolateral membrane upon interaction with AQP2-insA
will result in decreased renal water reabsorption through the
apical plasma membrane, and therefore provides a cell-bio-
logical explanation for NDI in this particular family.
Apical sorting of proteins is mediated through formation
of glycolipid- and cholesterol-containing membrane subdo-
mains (i.e., rafts) in the TGN and through N-linked gly-
cans, but can also occur independently from these processes
(Scheiffele et al., 1995; Simons and Ikonen, 1997). No api-
cal sorting information has yet been identified in AQP2. Ba-
solateral sorting signals are thought to be dominant over api-
cal sorting information because fusion of basolateral sorting
motifs to apical proteins (Casanova et al., 1991), or even sin-
gle amino acid substitutions in an apical protein (Brewer
and Roth, 1991), can redirect these proteins to the basolat-
eral surface. The seemingly complete basolateral sorting of
wt-AQP2/AQP2-insA heterotetramers underscores this phe-
nomenon.
At present, only a few other diseases have been described
in which the introduction or deletion of a sorting signal is
the molecular basis of a disease. A mutant low density lipo-
protein receptor, which was found in familial hypercholes-
terolemia, has a defect in one of its tyrosine-based motifs.
This mutant is missorted to the apical (instead of basolat-
eral) plasma membrane of MDCK cells and to the bile
canalicular (apical) surface of cultured hepatocytes and
mouse liver in vivo (Koivisto et al., 2001). In addition, early
stop mutants of the cystic fibrosis transmembrane conduc-
tance regulator, which lacked a PDZ motif and were not
able to bind the apical membrane protein EBP50, accumu-
lated at the basolateral membrane (Moyer et al., 1999).
However, both proteins are thought to function as mono-
mers because cystic fibrosis is a recessive trait and familial
hypercholesterolemia has a dominant form of inheritance
probably caused by haplotype insufficiency. As such, our
data reveal a novel cellular phenotype in dominant NDI and
show for the first time that dominance of basolateral target-
ing motifs in mutant subunits over apical targeting signals in
wt subunits in a heterotetramer can be the molecular basis of
a dominant disease. Because many ion channels in diseases
are expressed as multimers (e.g., ROMK1, KIR6.2; Glo-
watzki et al., 1995; Tinker et al., 1996; Verkarre et al.,
1998), missorting of a channel complex due to the introduc-
tion of sorting motifs in a mutant monomer might also be
fundamental to other dominant diseases.
 
Materials and methods
 
Patients: clinical analysis, haplotype analysis, 
and mutation detection
 
Clinical analysis of blood and urine osmolarities was done by standard
procedures. Haplotype analysis was performed for three dinucleotide re-
peats (
 
AFM259vf9
 
, D12S131, and AFMb007yg5) flanking the AQP2 gene
(LeBlanc Straceski et al., 1994), and for a putative benign mutation of the
AQP2 gene (c.836A C, 3  UTR). For interpretation of the haplotype data,
we assumed no recombination within an  1.5-megabase region spanned
by AFM259vf9 and AFMb007yg5. The provided haplotype data support
the consistency of the stated biologic parentage within the pedigree. Iden-
tification of the AQP2 gene mutations described in this paper was essen-
tially done as described earlier (Bichet et al., 1993).
DNA constructs
General. Mutations were introduced by in vitro mutagenesis (altered sites
[Promega] or QuikChange
® [Stratagene]) or PCR using Pfu DNA polymer-
ase (Stratagene). Clones with the desired mutations were identified by the
introduced restriction sites (underlined), after which the proper sequence
of the inserts was verified by DNA sequence analysis.
Oocyte expression constructs. To introduce the AQP2–779–780insA mu-
tation into the AQP2 cDNA, the primer 5 -GGTGGAGCTGCAGCTGGC-
CGCAGAGCCT-3  was with pAlter-AQP2 (Mulders et al., 1998). Instead
of an adenosine, a guanidine (bold) was inserted to silently introduce a
PvuII site. A 200-bp NarI and blunted HindIII fragment, containing the mu-
tation, was isolated and cloned into the NarI and EcoRV sites of pBS-AQP2
(Deen et al., 1994), generating pBS-insA. Next, a 282-bp BamHI/KpnI frag-
ment from this clone was subcloned into the corresponding sites of pT7TS-
wt-AQP2 to create pT7TS-insA-1. Because the AQP2–779–780insA muta-
tion extends the protein by 14 amino acids, the 3  UTR of the human
AQP2 gene needed to be cloned in. Therefore, a 426-bp PCR fragment
was generated from human genomic DNA using the forward primer 511FBasolateral misrouting of AQP2 in dominant NDI | Kamsteeg et al. 1107
(5 -CACCGGCTGCTCTATGAATCCT-3 ) and the reverse primer (5 -ACT-
AGTCAGACTGCGGGAGAGGAGGGACG-3 ), and was subcloned into
the EcoRV site of pBSIIKS . Subsequently, the c836A C mutation, which
was also found in the mutant AQP2 allele, was introduced with the
forward primer 5 -CCTGAGGGCCGCTAGCGGCCTCTACGGCCCCGA-
CGG-3 . From this clone, pBS-UTR, an 80-bp KpnI/blunted ApaI fragment
was isolated and cloned into the KpnI/blunted SpeI sites of the oocyte’s ex-
pression vector pT7TS-insA to generate pT7TS-insA.
The insA-R273* and insA-G268* mutations were introduced by PCR on
pBS-insA using the 533F forward primer 5 -CCCCTGCTCTCTCCAT-
AGGC-3  and the reverse primers 5 -GTACCAAGGCCTCTAGACCGC-
CAGCCCGT-3  and 5 -AGAGCCTGCCACCTAGGACCAAGGCCTGA-3 ,
respectively. The PCR fragments were digested with BamHI and ligated
into the EcoRV/BamHI sites of pBS-AQP2. From these clones, 320-bp
BamHI/blunted HindIII fragments were isolated and cloned into the
BamHI/blunted SpeI sites of pT7Ts-AQP2, resulting in pTsT7-insA-R273*
and pTsT7-insA-G268*.
Mammalian expression constructs
The AQP2-S261*–encoding mutation was obtained with the reverse primer
5 -GAGCTGCACTAGTCGCAGAGCCT-3 . Subsequently, a 282-bp BamHI/
KpnI AQP2 fragment of pTsT7-AQP2 was exchanged for its mutant frag-
ment. pCB6-AQP2-S261* was made by ligation of the 870-bp BglII/SpeI
fragment from pTsT7-AQP2-S261* into BglII/XbaI-restricted pCB6. To gener-
ate pCB6-AQP2-R187C, a BglII/SpeI fragment from pTsT7-AQP2-R187C
(Deen et al., 1994) was subcloned into the BglII/XbaI sites of pCB6. To facil-
itate cloning of other AQP2 cDNAs into pCB6, the BamHI site of pCB6 was
removed. To clone AQP2-insA into pCB6, a two-step cloning procedure was
performed. First, a 120-bp KpnI fragment from pBS-UTR was cloned into the
KpnI site of pBS-insA. Second, a 950-bp blunted EcoRI/XbaI fragment was
cloned into the blunted SacI and XbaI sites of pCB6 BamHI. pCB6-insA-
R273* and pCB6-insA-G268* were made by ligation of 920-bp NotI/HincII
fragments of pBS-insA-R273* and pBS-insA-G268*, respectively, into NotI/
blunted XbaI pCB6. The pCB6 constructs encoding insA-L261A, insA-
Y269A, insA-E264*, insA-Y279*, and insA-D282* were obtained with the
forward primers 5 -GGAGCTGCAGGCCGCCGCGGAGCCTGCCAC-3 , 5 -
CGCAGAGCCTGCCACGGGGGCCCAAGGCCTGAGGGCCGC-3 , 5 -GCT-
CGCCGCATAAGCTTCCACGGGGTACC-3 , 5 -CCTGAGGGCCGCTAGC-
GGCCTCTAAGGCCCCGACGG-3 , and 5 -GCGGCCTCTACGGCCCC-
TAGGGACGCTTGTG-3 , respectively, and a pCB6 BamHI template. For
pCB6-insA-L261A-G268* and pCB6-insA-L261A-Y269A, the insA-L261A
primers were used on pCB6-insA-G268* and pCB6-insA-Y269A templates,
respectively. Subsequently, the BamHI/XbaI fragment of pCB6 BamHI was
exchanged for that of those seven mutants.
To generate a construct encoding VSV-G–tagged AQP2-insA, a 300-bp
BamHI/HincII fragment from pBS-insA was isolated and ligated into the
BamHI/blunted SalI sites of pBS-wt-VSV-G-AQP2 (Kamsteeg et al., 1999).
Subsequently, a blunted NotI/HindIII fragment from this clone was sub-
cloned into the blunted BglII/HindIII sites of pCB6. To generate pEGFP-
AQP2-R187C, a 1,083-bp blunted NspI/SalI fragment of pTsT7-AQP2-
R187C (Deen et al., 1994) was isolated and cloned into the HindIII
blunted/SalI sites of pEGFP-C1 (CLONTECH Laboratories, Inc.).
AQP2 antibodies
Affinity-purified antibodies specific for the COOH terminus of AQP2 (AQP2
COOH-terminal antibodies) and those raised against aa 175–269 of human
AQP2 (AQP2 antibodies) have been described previously (Deen et al., 1994;
Mulders et al., 1998). To generate AQP2-insA antibodies, a 275-bp PvuII frag-
ment, encoding the C-tail of AQP2-insA, was isolated from pBS-insA and li-
gated into the SmaI site of pGEX3X (Amersham Biosciences). The isolation of
the soluble GST fusion protein and generation of affinity-purified AQP2-insA
antibodies was done as described previously (Marr et al., 2002b).
Expression in oocytes
Transcription of pT7Ts constructs, and isolation, injection, and Pf measure-
ments of Xenopus oocytes were done as described previously (Mulders et
al., 1998). Total and plasma membranes were isolated as described previ-
ously (Kamsteeg and Deen, 2001). Immunocytochemistry was done as de-
scribed elsewhere (Mulders et al., 1998) using 1:50 diluted affinity-purified
AQP2 antibodies.
Membrane isolation from MDCK cells
To isolate total membranes, MDCK cells were grown to confluence in a
10-cm dish, scraped in PBS, and spun down at 200 g for 5 min at 4 C. The
cells were homogenized in 2.5 ml HbA (20 mM Tris, pH 7.4, 5 mM MgCl2,
5 mM NaH2PO4, 1 mM EDTA, 80 mM sucrose, and protease inhibitors) us-
ing a mortar and pestle. Unbroken cells and nuclei were removed by cen-
trifugation at 1,000 g for 10 min at 4 C. Membranes were spun down at
100,000 g for 1 h at 4 C.
Differential velocity centrifugation and immunoprecipitation
Membranes of MDCK cells from a 10-cm dish or membranes of 60 oocytes
were solubilized in 300  l 4% sodium-deoxycholate. Gradient centrifuga-
tion and immunoprecipitation of protein complexes from these solubilized
membranes was performed as described previously (Kamsteeg et al.,
1999). Specific immunoprecipitation of AQP2-insA was performed simi-
larly, using 30- l equivalents of protein G–agarose beads (Amersham Bio-
sciences), preincubated with 10  l affinity-purified guinea pig AQP2-insA
antibody.
Immunoblotting
PAGE, blotting, and blocking of the membranes was performed as de-
scribed previously (Kamsteeg et al., 1999). Membranes were incubated
overnight with a 1:3,000 dilution of affinity-purified rabbit AQP2 or
AQP2-COOH-terminal antibodies. In experiments where the expression
levels between wt-AQP2 and AQP2-insA were compared, the AQP2 anti-
bodies were completely preabsorbed with a synthetic peptide raised
against the last 15 amino acids of AQP2. Preabsorption was complete
when the wt/wt ratio of peptide versus antibody was 3. All primary anti-
bodies were diluted in TBS-T (20  M Tris, 140 NaCl, and 0.1% Tween 20,
pH 7.6) supplemented with 1% nonfat-dried milk. Blots were incubated
for 1 h with 1:5,000-diluted goat anti–rabbit IgGs or 1:2,000 goat anti–
mouse IgGs (Sigma-Aldrich) as secondary antibodies coupled to HRP. Pro-
teins were visualized using ECL (Pierce Chemical Co.).
Culture and immunocytochemistry on MDCK cells
MDCK cells were grown and transfected, and immunocytochemistry and
collection of images were performed as described previously (Deen et al.,
2002). Three clonal cell lines per mutant were analyzed to exclude the
possibility that clonal differences might cause the observed phenotypes. As
primary antibodies, a 1:100 dilution of affinity-purified rabbit AQP2 or
AQP2-COOH-terminal antibodies, a 1:10 dilution of affinity-purified
guinea pig AQP2-insA, or a 1:500 dilution of affinity-purified rat E-cad-
herin antibodies (Sigma-Aldrich) were used. As secondary antibodies,
1:100 dilutions of affinity-purified goat anti–rabbit IgG coupled to Alexa
®
488 (Molecular Probes, Inc.), affinity-purified goat anti–guinea pig IgG
coupled to Alexa
® 594 (Molecular Probes, Inc.), or affinity-purified anti–rat
IgG coupled to Cy5 were used. As controls, nontransfected cells revealed
no labeling for AQP2. Note that in the colocalization analysis of wt-AQP2
and G-AQP2-R187C, the antibodies recognizing wt-AQP2 also recognize
G-AQP2-R187C. However, due to the weak expression of G-AQP2-
R187C, wt-AQP2 could be well discriminated from G-AQP2-R187C. Fi-
nally, preparations were embedded in Vectashield
® (Vector Laboratories).
Image acquisition and manipulation
Horizontal and vertical images were obtained with a confocal laser-scan-
ning microscope (MRC 1000; Bio-Rad Laboratories), using a 60  oil lens
with NA of 1.4, and with LaserSharp 2000 software (Bio-Rad Laboratories),
applying a 3  zoom and an iris of 3. Subsequently, images were imported
and merged in Adobe Photoshop
® 7.0, and brightness and contrast were
adjusted.
Computer-assisted image analysis
To create a semi-objective index for surface versus intracellular expression
of the AQP proteins, mean values of integrated optical density (IOD) of
surface or intracellular segments were determined using Image Pro Plus
analysis software (Media Cybernetics). The basolateral plasma membrane
segments were identified by the signal for E-cadherin. Background IOD
values were determined within the nuclear area of the particular cell and
subtracted from the obtained surface and intracellular IOD values. The ra-
tio of surface to intracellular expression is defined as the corrected IOD of
the surface segment divided by the corrected IOD of the intracellular seg-
ment. Of eight independent cells from unsaturated images and three seg-
ments of the surface and intracellular areas per cell, the mean ratio of sur-
face/intracellular expression   SEM was determined.
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